|
1) Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest. 1994; 70: 299-306
|
|
|
|
2) Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin. Immunol. 2004; 113: 395-400
|
|
|
|
|
|
3) Bloomfield SF, Stanwell-Smith R, Crevel RW, et al. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006; 36: 402-5
|
|
|
|
|
|
4) Strunk RC, Bloomberg GR. Omalizumab for asthma. N Engl J Med. 2006; 354: 2689-95
|
|
|
|
|
5) Corren J, Busse W, Meltzer EO, et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4R alpha antagonist, in patients with asthma. Am J Respir Crit Care Med. 2010; 181: 788-96
|
|
|
|
|
|
6) Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009; 360: 985-93
|
|
|
|
|
|
7) Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009; 360: 973-84
|
|
|
|
|
|
8) Flood-Page P, Swenson C, Faiferman I, et al. International Mepolizumab Study Group. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007; 176: 1062-71
|
|
|
|
|
|
9) Strachan DP. Hay fever, hygiene and household size. Br Med J. 1989; 299: 1259-60
|
|
|
|
|
|
10) Weiss ST. Eat dirt -the hygiene hypothesis and allergic diseases. N Engl J Med. 2002; 347: 930-1
|
|
|
|
|
|
11) Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001; 1: 69-75
|
|
|
|
|
|
12) Anderson WJ, Watson L. Asthma and the hygiene hypothesis. N Engl J Med. 2001; 344: 1643-4
|
|
|
|
|
|
13) Douwes J, Pearce N, Heederik D. Does environmental endotoxin exposure prevent asthma？ Thorax. 2002; 57: 86-90
|
|
|
|
|
|
14) Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol. 2002; 109: 379-92
|
|
|
|
|
|
15) Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140: 805-20
|
|
|
|
|
|
16) Hashimoto S, Matsumoto K, Gon Y, et al. Viral infection in asthma. Allergol Int. 2008; 57: 21-31
|
|
|
|
|
17) Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000; 161: 1501-7
|
|
|
|
|
|
18) Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000; 1: 398-401
|
|
|
|
|
|
19) Saitoh S, Miyake K. Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev. 2009; 227: 32-43
|
|
|
|
|
|
20) Gon Y. Toll-like receptors and airway inflammation. Allergol Int. 2008; 57: 33-7
|
|
|
|
|
|
21) Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004; 4: 978-88
|
|
|
|
|
|
22) GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol. 2008; 1: 442-50
|
|
|
|
|
|
23) Barrett NA, Maekawa A, Rahman OM, et al. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J Immunol. 2009; 182: 1119-28
|
|
|
|
|
|
24) Sertl K, Takemura T, Tschachler E, et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med. 1986; 163: 436-51
|
|
|
|
|
|
25) GeurtsvanKessel CH, Willart MA, van Rijt LS, et al. Clearance of influenza virus from the lung depends on migratory langerin＋CD11b- but not plasmacytoid dendritic cells. J Exp Med. 2008; 205: 1621-34
|
|
|
|
|
|
26) Jahnsen FL, Strickland DH, Thomas JA, et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol. 2006; 177: 5861-7
|
|
|
|
|
|
27) Sung S, Fu SM, Rose Jr CE, et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol. 2006; 176: 2161-72
|
|
|
|
|
|
28) Van Rijt LS, Jung S, Kleinjan A, et al. In vivo depletion of lung CD11c＋ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med. 2005; 201: 981-91
|
|
|
|
|
|
29) Raymond M, Rubio M, Fortin G, et al. Selective control of SIRP-a＋ airway DC trafficking through CD47 is critical for the development of Th-2 mediated allergic inflammation. J Allergy Clin Immunol. 2009; 124: 1333-42
|
|
|
|
|
|
30) Holt PG, Haining S, Nelson DJ. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol. 1994; 153: 256-61
|
|
|
|
|
|
31) De Heer HJ, Hammad H, Soullie T, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med. 2004; 200: 89-98
|
|
|
|
|
|
32) del Rio MJ, Rodriguez-Barbosa JI, Kremmer E, et al. CD103- and CD103＋ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4＋ and CD8＋ T cells. J Immunol. 2007; 178: 6861-6
|
|
|
|
|
|
33) Vermaelen KY, Carro-Muino I, Lambrecht BN, et al. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med. 2001; 193: 51-60
|
|
|
|
|
|
34) Jakubzick C. Bogunovic M, Bonito AJ, et al. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med. 2008; 205: 2839-50
|
|
|
|
|
|
35) Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma immunity. 2009; 31: 412-24
|
|
|
|
|
|
36) Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009; 15: 410-6
|
|
|
|
|
|
37) Nolte MA, Leibundgut-Landmann S, Joffre O, et al. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo. J Exp Med. 2007; 204: 1487-501
|
|
|
|
|
|
38) Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest. 1999; 104: 123-33
|
|
|
|
|
|
39) Eisenbarth SC, Piggott DA, Huleatt JW, et al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002; 196: 1645-51
|
|
|
|
|
|
40) Jung YW, Schoeb TR, Weaver CT, et al. Antigen and lipopolysaccharide play synergistic roles in the effector phase of airway inflammation in mice. Am J Pathol. 2006; 168: 1425-34
|
|
|
|
|
|
41) Phipps S, Lam CE, Kaiko GE, et al. Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th2 responses. Am J Respir Crit Care Med. 2009; 179: 883-93
|
|
|
|
|
|
42) Rank MA, Kobayashi T, Kozaki H, et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009; 123: 1047-54
|
|
|
|
|
|
43) Kouzaki H, O'Grady SM, Lawrence CB, et al. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol. 2009; 183: 1427-34
|
|
|
|
|
|
44) Jacob C, Yang PC, Darmoul D, et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem. 2005; 280: 31936-48
|
|
|
|
|
|
45) Gruber A, Mancek M, Wagner H, et al. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem. 2004; 279: 28475-82
|
|
|
|
|
|
46) Trompette A, Divanovic S, Visintin A, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature. 2009; 457: 585-8
|
|
|
|
|
|
47) Ramaprakash H, Hogaboam CM. Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and-independent manner. Int Arch Allergy Immunol. 2010; 152: 98-112
|
|
|
|
|